Home | About | Journals | Submit | Contact Us | Français |

**|**PLoS One**|**v.7(7); 2012**|**PMC3406091

Formats

Article sections

Authors

Related links

PLoS One. 2012; 7(7): e40806.

Published online 2012 July 26. doi: 10.1371/journal.pone.0040806

PMCID: PMC3406091

Masaru Katoh, Editor^{}

National Cancer Center, Japan

* E-mail: rf.srnc.nlni@erhclupes.erdnaxela-seuqcaj

Conceived and designed the experiments: JAS ACV. Performed the experiments: JAS ACV. Analyzed the data: JAS ACV. Wrote the paper: JAS SDM ACV.

Received 2012 March 21; Accepted 2012 June 13.

Copyright Sepulchre et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been cited by other articles in PMC.

In biochemical signaling pathways without explicit feedback connections, the core signal transduction is usually described as a one-way communication, going from upstream to downstream in a feedforward chain or network of covalent modification cycles. In this paper we explore the possibility of a new type of signaling called retroactive signaling, offered by the recently demonstrated property of retroactivity in signaling cascades. The possibility of retroactive signaling is analysed in the simplest case of the stationary states of a bicyclic cascade of signaling cycles. In this case, we work out the conditions for which variables of the upstream cycle are affected by a change of the total amount of protein in the downstream cycle, or by a variation of the phosphatase deactivating the same protein. Particularly, we predict the characteristic ranges of the downstream protein, or of the downstream phosphatase, for which a retroactive effect can be observed on the upstream cycle variables. Next, we extend the possibility of retroactive signaling in short but nonlinear signaling pathways involving a few covalent modification cycles.

One of the most vital processes in biology is the transduction of signals along biochemical pathways, enabling the living cell to elicit appropriate responses to chemical and physical stimuli [1]. In this context, the concept of signaling cascade is used as a paradigm or a model of signaling pathways. It consists of a chain of enzymatic reactions wherein a protein is interconverted reversibly between two forms. At each stage in the cascade, the activated form of the protein, which usually is a covalently modified derivative of the native protein, serves as the enzyme to activate the protein in the next stage in the chain and so on. Thus, a signaling cascade consists of a succession of covalent modification cycles, whose classical representative example is the phosphorylation/dephosphorylation cycle, but the general concept is broadly applicable. In some important cases, such as the well-studied MAPK cascades, the stages are in fact composed of double phosphorylations [2], [3]. In all cases, the concept of cascade clearly indicates a notion of flow oriented unidirectionally.

A general intracellular signaling network may consist of several interconnected cascades [4]. Its topology can then be described as an oriented graph whose nodes represent stages of the cascades and the arrows serve to relate the activated proteins at a given stage to other covalent modification cycles or to a substrate targeted by the network. Associated with such a graph one may define several signaling pathways, namely several paths in the oriented graph, going from a top vertex, representing a biochemical entry of the system, e.g. a ligand, towards the bottom stage of one of the cascades, e.g. a transcription factor for some genes. A simple type of signal that can be transmitted in this system is a step increase of the enzyme activating the top cycle of one signaling pathway. Several studies have been devoted to the modeling of the propagation of such signal in signaling chains, and on the transmission properties as a function of most of the parameters of the cascade [3], [5]–[7].

The mathematical modeling of signaling pathways often considers a simplified set of equations in which each cycle is described by a single variable [5]. In a previous study, we highlighted that these simplified models overlooked the property of retroactivity between two successive stages of the cascades, and we proposed a new type of simplified modeling for cascades to account for this important signaling property [8]. The concept of retroactivity means that the response property of a well-characterized input/output isolated device can change dramatically when this device is coupled to a downstream load. In the context of signaling pathways, retroactivity is a phenomenon that arises due to enzyme sequestration in the intermediate complex enzyme-next protein in the cascade. Its main consequence is that a downstream perturbation -e.g. of the protein- can produce a response in a component upstream of the perturbation without the need for explicit feedback connections. In refs. [8], [9] this effect was described independently by two groups for the first time. The main focus in ref. [8] was to derive a simplified description of signaling cascades with one variable per cycle while keeping the retroactive property, after noticing that the standard simplifications on modeling cascades were explicitly avoiding such effects. The study of the effect (referred to as retroactivity in [9]) was done mostly numerically in [8], introducing the notion of “reverse stimulus response curve”. Now, we study in detail reverse stimulus response curves, by characterizing both analytically and numerically when to expect a measurable upstream effect due to a downstream change in a control parameter. This work provides a roadmap for planning experiments that carefully account for this phenomena.

The absence of retroactivity for a signaling module implies that the state variables of this module do not change when its output is used as the input of another device. Special conditions are to be met in the design of a network unit in order to minimize the retroactivity [9], [10]. In the context of engineering, and specifically in synthetic biology where modularity is required [11]–[13], retroactivity is usually considered as a nuisance, often preventing the proper functioning of devices that consists of assemblies. The property of pathway retroactivity started to gain interest in the systems biology community [9], [14]–[16]. Retroactivity tends to be attenuated in long signaling cascades [7], [10]. However, ref. [10] also shows that the probability that a 3-stage cascade exhibits retroactivity is around 0.5, so under many commonly encountered conditions, retroactivity occurs. Indeed, recent experiments demonstrate that retroactivity can be set in evidence and measured *in vivo* in the MAPK cascade controlling the early development of drosophila embryos [17]. An *in vitro* study shows that retroactivity effects can be easily induced at one stage of the signaling system regulating the nitrogen assimilation in *E. coli*
[18]. In short, retroactivity can be experimentally demonstrated in signaling pathways. In the recent paper by Wynn et al [16], it is shown that an important consequence of retroactivity is its role in the cellular response to a targeted therapy. In particular, we characterized the fact that kinase inhibitors can produce off-target effects as a consequence of retroactivity. In this numerical study, a statistical methodology based on a random sampling of the parameter space was utilized. In particular, that study considered a signaling topology with 3 single cycles, where one of them activates the other two in parallel. This system is also analysed in the present paper which is based on a numerical and analytical study of the nonlinear equations. In that sense, both articles complement each other.

Moreover, in the present work, we make use of the property of retroactivity in order to extend, theoretically, the standard view of signaling to a new type of intracellular signaling. Indeed, the existence of retroactivity in signaling pathways turns the usually one-way oriented graphs mentioned above, into two-way oriented graphs, with arrows going now from downstream to upstream. We call *retroactive signaling* the design of a pathway that exploits this possibility, that is to say, an extended signaling pathway which comprises a connected path of upstream signaling from output to input (cf. Fig. 1). Since retroactivity is a secondary effect, when compared with the usual activation in signaling cascades, a retroactive signaling pathway would typically include only one or a few upstream arrows combined with the usual downstream arrows. Nevertheless, the possibility of retroactive steps in a signaling pathway opens up previously unexplored possibilities for signal transduction.

In this paper we explore this concept for the first time in short signaling pathways like the basic case of a 2-cycle cascade and simple extensions of it. The 2-cycle cascade, or the bi-cyclic cascade, is usually described as a motif comprising 2 cycles and a single arrow linking the activated protein of the first onto the second cycle. In this article, retroactive signaling in this system will be dealt with by analysing how a variation of the parameters affecting the downstream cycle, e.g. varying the total protein concentration in this cycle, or its phosphatase, can induce a response in variables of the upstream cycle. The upstream response can be computed numerically and estimated analytically. We will illustrate the theoretical work with examples of retroactive signaling in short multi-cycle pathways.

Figure 1 depicts simple motifs of 2-cycle and 3-cycle pathways. The goal is to study the conditions under which a signal, or a perturbation, that modifies the state of a *downstream* cycle, can be transmitted *upstream*, to another cycle in the context of these short pathways. We will focus most of our studies on what happens to the upstream cycle in a 2-cycle system, when control parameters of the downstream cycle are modified, as for instance its total available protein or its total phosphatase.

The mathematical equations describing these systems are discussed in the Methods section. To summarize our main notations, we name each cycle in a given signaling pathway by an index *i*(). We take the convention to call cycle 1 the starting cycle of a retroactive signaling scheme, and to increment the number of the other cycles following their position in the signaling network until the last cycle in the pathway has been reached. Figure 1(B) shows a simple example of retroactive signaling in the pathway 123 where cycle 2 is an enzyme for both cycles 1 and 3. For notational convenience we will use variable names to denote both a chemical species and its concentration. For instance, the instantaneous state of each cycle is described by the variables and , denoting respectively the concentrations of the inactivated and of the activated protein , whose total amount is denoted by . The enzymatic activations of a given stage of the cascade on the next stages are indicated by vertical top-down arrows on Fig. 1, except for the activation of the uppermost stage for which the activating enzyme is a parameter, e.g. denoting the total concentration of the enzyme converting into . In all cases, the enzyme deactivating cycle has a total concentration denoted by .

In most signaling systems, the activated form of protein *i* corresponds to its phosphorylated form, in which case the converting enzymes are called *kinase* and *phosphatase*, respectively for the phosphorylation and the de-phosphorylation of the protein. Since this situation is the most frequently present in intracellular signaling modules, in what follows we will often name the kinase and the phosphatase of cycle 2, just for brevity. Moreover, the activating covalent modification will be referred to as phosphorylation. In fact, all the formalism used in this study can equally well apply to other covalent modifications like adenlylation, methylation, GTP-ase modifications.

In order to describe the 2-cycle cascade (cf. Fig. 1(A)) from the point of view of retroactive signaling, let us start by suppressing the phosphatase in the upstream cycle, i.e. set in cycle 2. Then, cycle 1 behaves like a single signaling cycle with kinase and with phosphatase . Let us analyse what happens to the activated and the non-activated proteins in cycle 1, when the total available amount of this protein, denoted by , is varied between and an arbitrarily large value. In what follows, we will see that answering this question will provide a way to analyse simple instances of retroactive signaling.

The intermediate complex formed by enzyme and protein is a key chemical species in the coupling between cycle 2 and cycle 1. Thus it is relevant to study how grows when the total protein of cycle 1 is increased from the value . Figure 2(B) shows the case where cycle 1 is deactivated (*i.e.*
). Then, first increases proportionally to , and reaches a plateau corresponding to its saturated value, , when . This saturating behavior suggests the definition of a characteristic range for the variation of , meaning that above this range a further increase of total protein in cycle 1 has not much effect on the sequestration of protein in cycle 2. For example, we can define the characteristic range for by extrapolating the initially linear growth of as a function of to its asymptotic value . This is indicated and denoted on Fig. 2 by . This characteristic range of can be analytically calculated as a function of the parameters of cycle 1. The result is:

(1)

where and are the maximal reaction rates defined in Eq.(19), and are the Michaelis-Menten coefficients of the cycle 1 (cf. section Methods). The quantity will be used in the following in order to non-dimensionalize the parameter by scaling it with whenever is plotted (e.g. in abscissa).

Figure 2(C) shows the increase of when cycle 1 is activated (). It can be shown that in this case the maximum amount for is , with , meaning that the sequestration is lower than in the case where cycle 1 is deactivated. Therefore, we will see in the next Section that in order to optimize the retroactivity in a 2-cycle system, the downstream cycle should be deactivated, so that varying has a larger effect on and thereby a greater influence on the upstream cycle.

At the same time, two distinct behaviors are seen for variables () as a function of total , according to whether cycle 1 is activated or not (cf. Fig. 2(D-E)). If cycle 1 is deactivated the asymptotic behavior is a linear increase of variable while tends to a constant. If cycle 1 is activated, the converse happens, namely grows linearly and reaches a constant value. Therefore, increasing the amount of substrate beyond the characteristic range in the covalent modification cycle 1 tends to an increase of either the activated or of the deactivated protein, but not of both, and the other variable tends to a constant. These latter values can be computed analytically as follows, if (cf. the section Methods):

- if then(2)
- if then(3)

Figures 2(D-E) illustrates also that the graphs of and as a function of can be sketched by piecewise linear approximations. In particular, the initial slope of with respect to is found to be , whereas the initial slope of is (cf. section Methods).

The results of this section were obtained by assuming absence of phosphatase in cycle 2, so that cycle 1 behaved as an isolated cycle. In the general case of a 2-cycle system, with some phosphatase acting in the upstream cycle (), the obtained results can change, but the modifications are worked out in the Method section. Particularly, one shows that the characteristic range for , which are now denoted by , has a similar expression to the one defined by Eq.(1), but replacing in this equation by , where is the phosphorylated protein in cycle 2, in the limit of vanishing . Nevertheless, it appears that (Eq.1) is useful as an upper bound of the characteristic range , whose a lower bound is given by . Regarding the behavior of the cycle when , Eq.(2) still holds whatever the value of is, if . On the other hand, when and , the limit (3) gives the final value of only approximately. The exact asymptotic behavior of , which cannot be formulated as a simple analytical expression, is given in the Method section (cf. Eq.(39)).

Having gained insight into how a covalent modification cycle behaves when its total protein is varied, we ask how the cycle 2, which is upstream with respect to cycle 1, can be influenced by varying parameters of the downstream cycle. In an experimental setup, the downstream cycle 1 can be characterized by 2 control parameters, namely the total protein as seen before, and the amount of phosphatase acting on the deactivation of cycle 1, i.e. . In this section the considered control parameters of the 2-cycle cascade will be or .

What kind of variables can we measure on the upstream cycle to observe the effect of varying the control parameters of the downstream cycle? One possibility is to measure the fraction of activated (e.g. phosphorylated) protein in cycle 2 [17]. The latter is defined by:

(4)

Indeed the intermediate complexes and both contain some fraction of the phosphorylated protein in cycle 2. In particular, represents the fraction of activated protein 2 that is sequestered in cycle 1. Thus this variable embodies the coupling between the two cycles and the source of retroactivity.

Figure 3 shows the variations of the activated fraction as a function of parameters and under several conditions, depending on cycle 2 is activated or not. As will become clearer in the next sections, the main message of Fig. 3 is that varying the downstream parameters, the retroactivity on the phosphorylated fraction is significant only when the upstream cycle starts in deactivated state (left column). It is relatively negligible however, when the upstream cycle starts out activated.

Let us consider in detail the effect of varying the total protein in cycle 1. In practice, this can be achieved in various ways, e.g. by overexpressing the gene coding for protein 1, or by interfering with this quantity by adding a drug able to inhibit this protein [16], or by sequestration of resulting from modifying its substrates [19]. Since the retroactive control of cycle 1 on cycle 2 depends crucially on the complex , the relevant range of variation for can be estimated by given by Eq.(1). Therefore, the graphs presented in Figs. 3(B-C) show variations of over a range of , which is adequate to capture the significant variations of the activated fraction of protein 2 induced by varying . Figure 3(B) shows that when cycle 2 is deactivated, the variation of can pass from a value close to to a value close to . Moreover the amplitude variation of is maximum when cycle 1 is deactivated. In the latter case, we have seen in the previous section that the non-activated protein grows proportionally to (Fig. 2(D)). This arbitrarily large increase of the substrate of causes the saturation of enzyme 1 for cycle 1 and the complex increases towards its maximal allowed value like in Fig. 2(B). Therefore, by increasing , the phosphorylated fraction tends to its maximal value ; in this case we have a phenomenon of *total sequestration* of protein 2 in cycle 1.

On the other hand, if cycle 1 is activated and cycle 2 is still deactivated, the results of the previous section show that reaches only a fraction of total protein 2, namely (Fig. 2(C)). Here we observe a phenomenon of *partial sequestration* of species 2 by cycle 1. Once this partial sequestration has occurred, a further increase of has no longer an effect on the upstream cycle 2. The latter behaves then as a single covalent modification cycle with a reduced amount of protein 2, equal to . Therefore, the fraction saturates sooner than before and remains inferior to . It is seen on Fig. 3(B) (thin red lines) that a piecewise-linear sketch for the variations of is sufficient to describe the behavior of as a function of .

Finally, the case where cycle 2 starts out activated is depicted on Fig. 3(C). In this situation, the phosphorylated fraction hardly varies whatever the value of is, especially if cycle 1 starts out also activated. If it is deactivated, the variation of is non zero, but very weak. In conclusion, in order to enhance the retroactive control of cycle 1 on cycle 2, that is to get the larger possible increase of the fraction of phosphorylated protein in cycle 2, and this as a function of parameter of cycle 1, one should start from a situation where both cycles 1 and 2 are deactivated.

We turn now to the retroactive effect of varying the phosphatase of the downstream cycle, , on the fraction of phosphorylated protein in cycle 2. Here the total protein is fixed. Figures 3(D-E) show the variation of the phosphorylated fraction as a function of , that is a non-dimensionalized parameter proportional to (Eq.(19)). In the same manner as before, one observes that the phosphorylated fraction exhibits a significative variation only in the case where cycle 2 is deactivated (Fig. 3(D)). Moreover, the variation of is seen only when the control parameter varies in the interval , that is when cycle 1 passes from its activated to its deactivated state. Then, the level of increases proportionally to , until reaching a plateau depending on the chosen amount of . This plateau, that is the maximum fraction of upstream protein 2 that can be phosphorylated by increasing the phosphatase of the downstream cycle, can be predicted by the expression:

(5)

This equation is derived below, in the section Methods. In this equation, is the maximum free protein 2 that is activated in the limit of arbitrarily large phosphatase . Thus it is unknown a priori but, as a first approximation, it can be replaced by (the value of in absence of cycle 1). To get a better estimate, the actual value of can be found by using an iterative process.

Equation (5) allows us to estimate the level of necessary to reach a given fraction in the limit of large phosphatase :

(6)

In summary, in a 2-cycle cascade, in order to create conditions that may substantially modify the fraction of the activated protein in the upstream cycle by perturbing the parameters of the downstream cycle, it is recommended to deactivate the upstream cycle 2. Then, if the downstream cycle 1 is also maintained deactivated a substantial change in can be obtained by varying the total protein in the downstream cycle, within a range , where can be computed as a function of the system parameters (Eq.(1)). In the case where the downstream cycle is activated, it is also possible to change by varying the total protein, but in a smaller range than before, namely . Varying the phosphatase of the downstream cycle will not modify , if cycles 1 and 2 are both deactivated. If, on the other hand, the downstream cycle is activated, then a retroactive signaling in can be achieved by modifying the downstream phosphatase, provided that the total protein 1 is sufficiently abundant (cf. Eq.(6)).

The above analysis focussed on the changes of the fraction of phosphorylated protein in cycle 2 because the variable is experimentally accessible. However, it is also interesting to describe the behaviors of the 2-cycle cascade in terms of the free proteins in cycle 2, respectively and , as will be covered in the next section. Indeed, as discussed below, and are responsible for the possible crosstalk effects in cascades with more than 2 cycles.

When the upstream cycle 2 is deactivated, Figs. 3(B,D) demonstrate that the phosphorylated fraction can be raised by increasing or from . How does this growth affect the amount of free non-active and active proteins in the upstream cycle? It is seen on Fig. 3(F) and (H) that the growth of coincides with a decrease of the non-active protein . Conversely, the variation of the free activated protein is negligible (not shown). Moreover, if cycle 1 is deactivated, addition of the substrate in cycle 1 can lead to a complete depletion of protein in the upstream cycle. The decrease of is roughly linear in the range , and then beyond this range it is inversely proportional, . When the downstream cycle is activated, the decrease of occurs on the smaller range and then reaches a plateau that can be analytically predicted (cf. thin continuous lines on Fig. 3)(F)). This situation reflects the phenomenon of partial sequestration of protein of cycle 2 in the dynamics of cycle 1.

As illustrated on Fig. 3(H), the variation of phosphatase in the downstream cycle can also retroactively affects the amount of non-activated protein , provided that cycle 1 is activated and that the quantity is large enough. This figure also shows that the variation of is well approximated by a linear decrease as a function of or, equivalently, of .

When the upstream cycle 2 is activated, Figs. 3(C,E) showed that a variation of control parameters in cycle 1 entailed only minor changes in the fraction of phosphorylated protein in the upstream cycle 2. This result might convey the idea that when cycle 2 is activated no retroactivity can be observed on cycle 2. In reality, this view would be wrong, because in this case there can exist a large decrease of the free active enzyme , as illustrated on Figs. 3(G,I). Indeed, although the fraction stayed relatively constant on Figs. 3(C,E), these graphs showed also that the amount of protein 2 sequestrated by cycle 1 increased under a boost of the control parameters or . In fact, the growth of the intermediate complex is compensated by a corresponding decrease in , keeping a roughly constant total phosphorylated fraction . As before, to get a large variation of by making available more protein , cycle 1 should be deactivated, leading to the phenomenon of total sequestration in a range of (Fig. 3(G)). In contrast, if the control parameter is the phosphatase of the downstream cycle, then a retroactive response on cycle 2 is possible if the downstream cycle starts activated, while is large enough (cf. Fig. 3(I)).

The results obtained with a 2-cycle cascade can predict the effect of retroactivity in short signaling pathways with more than 2 cycles. We first consider a 3-cycle pathway where the activated protein in the cycle at the top of the pathway is an enzyme that activates two other cycles which are not directly linked together (Fig. 4(A)-(B)). In the last section we have demonstrated that a change in the parameters of a downstream cycle, for example the amount of phosphatase or the available protein of the cycle 1, can affect the state of the upstream cycle 2. More precisely, we anticipate that when the phosphatase is increased in cycle 1, it can augment the deactivated form of the protein . The latter then can bind to a greater amount of enzyme , which become less available for the activation of other substrates such as the protein in cycle 3. Therefore, to implement the scheme of retroactive signaling 123, we start by assuming that the upstream cycle 2 is activated and we consider a signal having the form of an increase in the phosphatase of the downstream cycle 1. We know from the above results (cf. Fig. 3)(I)) that to create a substantial variation in the upstream cycle 2, the phosphatase signal should switch the cycle 1 from an activated state to a deactivated state, considering at the same time a relatively large amount of available protein in cycle 1 (cf. Eq.(6)). Then Fig. 3(I) showed that the switching of the downstream cycle caused a complete decrease of the free phosphorylated enzyme in the upstream cycle 2. This behavior of can be considered as an output response of the pathway 12 that can be used as the input of the conventional signaling pathway 23. Therefore a retroactive signaling in the 3-cycle pathway 123 shown on Fig. 4 is promoted when there is a strong retroactivity on the segment 21, but a weak retroactivity on the segment 23 with respect to the considered input. Another condition is that, when the downstream cycle 1 is completely activated (i.e. when the phosphatase signal on cycle 1 is absent), cycle 3 should be activated by cycle 2. In this case only, it will feel the strong decay of the free phosphorylated enzyme in the upstream cycle 2 caused by its sequestration in the compounds of cycle 1. Figure 4(A) illustrates this type of signaling. One sees that cycle 3 can be switched on or off by varying the phosphatase regulating the input cycle 1.

A similar retroactive signaling in the same 3-cycle pathway can be achieved by modifying not the phosphatase but the available protein in the starting cycle 1. Keeping the same parameters as above, Fig. 4(B) shows that increasing the signaling protein 1 from a low value to four times the characteristic range entails a deactivation cycle 3. This happens because of the retroactive mechanism between cycles 1 and 2, as discussed in the previous section (cf. Fig. 3)(G)). In the latter case, the increase of the total protein available in the downstream cycle 1 downregulated the activated enzyme in the upstream cycle 2, assuming that the downstream cycle was deactivated. Here again, by combining a large retroactivity between cycles 1 and 2, but a low one between cycle 2 and 3, one achieves a retroactive signaling between cycle 1 and 3.

In some covalent modification cycles, the deactivated protein can serve also as an enzyme for another protein modification [18], [20]. For example a variation of the motif shown on Fig. 4(A) is a 3-cycle network consisting of one upstream cycle and 2 downstream cycles activated respectively by the phosphorylated and non-phosphorylated forms of protein in the upstream cycle. Then we checked that a change in the phosphatase of one downstream cycle can produce a transition in the other downstream cycle activated by the non-phosphorylated protein in the upstream cycle (not shown).

To extend the possibility of retroactive signaling to more complex situations than a 3-cycle pathways we now consider a motif of a 5-cycle network in which the activated protein in the top cycle acts as the enzyme regulating two 2-cycle cascades, as shown on Fig. 4(C). Can we produce in this case an example of retroactive signaling from one bottom cycle to the other bottom one, numbered respectively by 1 and 5, initiated for instance by a phosphatase variation in cycle 1? Here, the study of the 2-cycle and the 3-cycle systems reported above can also help to answer this question. In this 5-cycle pathway, the subnetwork formed by cycles 2-3-4 has the same topology than the 3-cycle pathway discussed previously. Therefore, since this latter subsystem is suitable for retroactive signaling, let us consider the subnetwork 2-3-4 with the same parameters as considered for the 3-cycle network of Fig. 4(B). Then we can link to this system the cycle 1 downstream to cycle 2, and the cycle 5 downstream to cycle 4. For recall, cycle 2 is deactivated. Now we use the result shown on Fig. 3(H), showing that increasing the phosphatase in cycle 1 is going to reduce the available protein in cycle 2 in such a way that the free activated enzyme in cycle 3 is strongly reduced. This, in turn, deactivates cycle 4, and then cycle 5 as for standard cascades. This example of retroactive signaling scenario is seen on Fig. 4(C) where the increase in the phosphatase in cycle 1 entails not only the deactivation of cycle 1 (not shown) but also the deactivation of the remote cycle 5. Let us remark that this crosstalk effect can propagate to possible downstream effectors activated by cycle 5.

Cell signaling is generally thought in terms of a series of reversible biochemical reactions that are chained together in a feedforward network where extra connections, called feedbacks, could regulate the information flow from bottom-up. In particular the expression “signaling cascade” was coined to suggest the idea of an upstream to downstream signal transmission. In the simplest scheme of a cascade of two covalent modification cycles, the input signal typically is a steep increase of the enzyme modifying the first protein. Then the latter acts as the enzyme activating the second protein whose concentration is interpreted as the output of this system. In this paper, however, we show that in such a cascade a retroactive signaling is also possible, i.e. transmitting an input signal from downstream to upstream, and we predict conditions for which this phenomenon can be observed. The input signal is now a variation of a biochemical species that can change the state of the downstream cycle. Two cases are considered, namely a change of the total amount of the downstream signaling protein, or a variation of the phosphatase deactivating the same protein. In both cases we work out characteristic ranges of the concentrations of the species for which a retroactive effect can be observed in the upstream cycle. Moreover we show that this potentiality can help to perform retroactive signaling in short multi-cycle pathways.

A covalent modification cycle is generally described as a two-state entity for which the total level of protein is fixed. However, like all the molecules inside the cell, this signaling protein is subjected to a turnover governed by several processes, including synthesis and degradation [21]. The changes in these processes alters the total level of proteins. For example the degradation of several signaling proteins is actively regulated by proteases, which has consequences on the signaling dynamics [22]. The present study shows that the variation of the total amount of available protein in a downstream signaling cycle can also affect the states of signaling modules upstream in the transduction cascade.

There are several ways to modify the available protein in the downstream cycle in a cascade of covalent modifications. One way is to change the amount of substrates to which the activated protein of the downstream cycle can bind. For example, in a recent study reported in [17], the authors perform experiments on the ERK/MAPK pathway associated with the syncytium state of the *Drosophila* embryo. They manage to modify the amount of substrates of the doubly phosphorylated form of ERK by constructing mutants missing the corresponding substrates. Another way to alter the available protein in the downstream cycle is to add in the medium a kinase inhibitor that can bind to the activated enzyme at the end stage of the pathway [16], [23]. Both ways can be modeled by considering an additional chemical reaction of the form:

(7)

where represents a substrate or a kinase inhibitor of the downstream protein . Then it can be shown that the set of stationary state equations of the signaling pathway is affected only in the conservation equation for the total protein . More precisely this latter quantity is replaced by , where 2 additional parameters characterize respectively the total amount of binding chemical species and the dissociation constant . Thus, the effect of varying is qualitatively analog to changing the amount of available protein . In particular, when the affinity of for protein 1 is high (i.e., small), the available downstream protein is approximately reduced by . Therefore under this hypothesis the upstream response in a 2-cycle cascade to a variation of can straightforwardly be inferred from the curves shown on Figs. 3. For instance, from Fig. 3(B) one predicts that in a 2-stage cascade increasing can decrease the phosphorylated fraction of the upstream protein, especially if the upstream cycle is in a deactivated state. This phenomenon may be the source of undesirable off-target effects in targeted therapies based on kinase inhibitors [16].

In Ossareh et al, the authors performed mathematical analysis of retroactivity in a signaling cascade with an arbitrary number of stages. They achieved necessary and sufficient conditions for which retroactivity exists in such chains. Their analysis is based on the linearization of the steady state equations in order to predict how a small downstream perturbation is amplified in the upstream response of an arbitrarily long signaling chain. Those results are complementary to the ones presented in the present paper, in the sense that here we consider short signaling pathways but our analysis is based on the resolution of the full nonlinear equations, and not only on the linearized system. So, it is concerned with arbitrarily large perturbations of the parameters. In fact we show that retroactive signaling is meant to work only for a characteristic range of parameter variations that we analytically estimate by working on the asymptotic behaviors of the system for small and large parameter perturbations.

Signaling pathways are regulated by several mechanisms, like positive or negative feedback loops linking the output of the cascades and some upstream stages. This requires the existence of specific chemical interactions between the output protein of the cascade and the upstream proteins that are involved in the feedback loop. Our study shows that the property of retroactive signaling can be another way to regulate the functioning of signaling cascades in branched pathways, without explicit feedbacks. In fact, we can further speculate that in natural signaling pathways with possibly several branches, some of the latter would be sensitive to retroactivity and be devoted to the regulation of the usual branches, where signals go in the top-down direction. These results prompt new experiments concerning signaling cascades and possibly new ways to interpret previous results.

Our theoretical study is performed in the framework of coupled nonlinear equations describing the rate of changes of protein concentrations in signaling cascades formed of covalent modification cycles. The model equations are deterministic and based on the law of mass action. Only stationary states of these equations are analysed and thus the mathematical method amounts to solving sets of algebraic nonlinear equations. Thus the issue of how the biochemical species reach the equilibrium is not discussed here, as it has been addressed in some previous studies [8], [9], [24]. In this respect our analysis is independent of questions related to possible time-scale differences between the kinetics of enzyme/substrate. For example, the usual quasi-steady state approximations are not to be considered since all the variables are at equilibrium.

Let us note that we assume that the studied signaling pathways possess a stable equilibrium. Although in this paper we will not explicitly discuss the generality of this assumption by performing the linear stability analysis of the equation set, the hypothesis of a stable equilibrium is consistent with the current knowledge. In the literature, published results indicate that non steady behaviors (e.g. sustained oscillations) can arise in signaling cascades only with the concomitant occurence of bistability in the signaling modules [6], [25]. However, this situation was only met with signaling modules described by double-phosphorylations cycles, like in the MAPK cascade. Here the considered signaling pathways do not include double-phosphorylation. Therefore this paper will not consider retroactive signaling in oscillating systems.

Let us introduce the notations used for writing the equations in the case of the simple 2-cycle cascade as depicted on Fig. 1(A). Assuming that this system is isolated from other biochemical reactions, the chemical equations describing the transformations of these species can be written as follows:

(8)

where and denote enzyme concentrations, whereas and () are intermediate enzyme-substrate complexes. These chemical equations readily generalize to the other motifs, e.g. the one shown on Fig. 1(B). The kinetic equations of the state variables of the cascades are written using the law of mass actions.

(9)

(10)

with the conservation laws for the total proteins and total enzyme concentrations :

(11)

(12)

Since we focus only on the stationary states of the system, the time-derivatives of the concentrations can be equaled to zero. This enables to express the variables and () in terms of the protein concentrations as follows:

(13)

(14)

with the coefficients () defined as a function of he kinetic parameters . One thus recognizes the usual Michaelis-Menten form for the substrate-enzyme complexes. The substitution of these expressions in Eqs.(9)–(10) and in the conservation laws given Eqs.(11)–(12) leads finally to 4 algebraic equations in the unknowns . Therefore a reduced set of equations (9–14) can be written as:

(15)

(16)

(17)

(18)

A 2-cycle cascade involves 4 enzymatic reactions. Each of those can be characterized also by their maximum reaction rates (). We denote the latter as follows:

(19)

The upper bound of the velocity , which describes the activation of , will depend on the total protein in cycle 2. In the following section we will seek the conditions under which the variations of parameters of cycle 1 produce a significant effect in cycle 2 due to retroactivity. As will be discussed, this property will depend on the states of the variables of both, upstream and downstream cycles. We will use the following terminology: cycle is said to be *activated* if . Otherwise, it is said to be *deactivated*. This property is easily related to the ratio in the symmetric case . Then cycle is activated if and only if
[5].

The following sections give details on the derivation of equations (1)–(3) and (5) used in the section Results.

Let us consider a 2-cycle cascade as drawn on Fig. 2(A), with total upstream protein , total downstream protein , and total deactivating enzyme and , respectively for the upstream and downstream cycles. We wish to determine a suitable value of that can be used as a characteristic dose of downstream protein inducing a retroactive effect on the upstream cycle. The steady state of this system is given by the solution of Eqs.(15)–(18). As motivated above, we focus on the behavior of , i.e. the intermediate substrate-kinase complex, which at equilibrium is given by . The change of as a function of the total protein is illustrated on Fig. 2(B)–(C) in the case where , but the behavior is the same if . It can be sketched by an increase of proportional to followed by a saturation to a constant value, that is when cycle 1 is deactivated (i.e. ). Therefore the quantity

(20)

defines a proper characteristic range of for the variation of . The upper index of reminds that the result of the right-hand side of this equality depends on the value of . In particular, we will be interested to the case which corresponds to the situation of the isolated signaling cycle 1 with kinase and with phosphatase . To simplify the notations, we will denote in the following:

(21)

and we will show that Eq.(1) holds with this definition. Since , one deduces that

(22)

Now, it suffices to compute the derivative of w.r.t. and evaluate it at . This can be analytically performed by differenciating each equation of the system (15)–(18) with respect to . This calculation provides a system of linear equations in the coupled variables . Solving this linear system we find that the solution can be written as:

(23)

(24)

(25)

(26)

where is the activated upstream enzyme when , and . Let us remark that or means respectively that the upstream cycle is highly activated or strongly deactivated.

By combining Eqs.(20), (22) and (25), one obtains the characteristic range for , as defined by Eq.(20):

(27)

In the case where , the upstream cycle is such that there is no phosphatase to deactivate it, so that and . In this case, using the definition , Eq.(27) becomes the sought relation Eq.(1), i.e.:

(28)

One easily shows that (because ). Therefore can be used as an upper bound of the characteristic range for . Particularly, if the downstream cycle is strongly activated, then and then is an excellent approximation of . On the other hand, if the downstream cycle is strongly deactivated, so that , one can use , that is the lower value reached by in the limit .

Let us note that using the definition of in the simple situation , the derivatives and in eqs.(25)–(26) can be written in a compact form, namely:

(29)

Incidently, these expressions give the initial slope of the curves drawn on Figs. 2(D-E).

Now, to justify Eqs.(2)–(3) given in the Results, we wish to compute the asymptotic values of in the limit of large . As suggested by the numerical computations, we first suppose that the asymptotic behavior of these variables are described by:

(30)

(31)

(32)

(33)

where are unknown constants to be worked out. Substitution of these relations in Eqs.(15)–(18) with determines . Since must be positive, this case is only consistent with the hypothesis , that is equivalent to Eq. (2) given in the Result section. Let us notice that here the result is independent on considering the case or not. The values of the other unknowns are found to be , , and

(34)

Secondly, in order to justify Eq.(3), we suppose another asymptotic behavior for the system variables in the limit of large :

(35)

(36)

(37)

(38)

where are new unknown constants to be determined. The calculation can be done in 2 steps. First can be calculated by solving Eqs.(15)–(16) which here becomes:

This system can be interpreted as finding the activated and deactivated proteins in the upstream cycle with the reduced amount of total protein . The latter must be positive, that is equivalent to the condition related to Eq.(3). The solution of this system is hard to write explicitly, except in the case where and .

The second step is to solve Eqs.(17)–(18) in the limit . Then one easily finds that , and therefore

(39)

where has been found in the first step. The latter equation generalizes Eq. (3), which holds in the case where . Then the simple expression of leads to the equality which is Eq. (3). Finally the value of is the same expression as Eq.(34), but swapping the “primed” and “not primed” parameters.

In conclusion, by using Eqs.(29)–(38), let us note that we can sketch the behavior of and of as a function of as piecewise linear graphs (see red lines on Figs. 2(D)–(E)).

Let us consider a 2-cycle cascade as drawn on Fig. 1(A) and suppose now that the control parameter is the quantity of phosphatase in the downstream cycle 1. We wish to prove the result of Eq.(5) giving the phosphorylated fraction of protein in cycle 2 in the limit of large .

First recall that is defined by the chemical compounds containing , namely (cf. Eq.(4)):

Thus, by using the steady expression for the complexes and , is also expressed as:

(40)

We wish to remove the dependency in of this expression. The steady state equations of cycle 1 can be written as follows:

(41)

Since is an enzyme, in the limit , none of the biochemical variables should diverge. Therefore the second equation in the above system implies that in this limit one has . Thus the Eq.(41) can be simplified into the form:

(42)

This enables to write as:

(43)

And by using this expression in Eq.(40), one finds Eq.(5), or:

(44)

**Competing Interests: **The authors have declared that no competing interests exist.

**Funding: **ACV is a member of the Carrera del Investigador Científico (CONICET) and was supported by the Department of Defense Breast Cancer Research Program, the Center for Computational Medicine and Bioinformatics (University of Michigan), and the Agencia Nacional de Promoción Científica y Tecnológica (Argentina). SDM receives funding from the Breast Cancer Research Foundation. The international program of scientific collaboration PICS 05922 between CNRS (France) and CONICET (Argentina) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

1. Nelson D, Cox M. Lehninger Principles of Biochemistry, Fourth Edition. W. H. Freeman, 1100 pp. 2004.

2. Seger R, Krebs EG. The mapk signaling cascade. FASEB J. 1995;9:726–35. [PubMed]

3. Huang CY, Ferrell JE. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1996;93:10078–83. [PubMed]

4. Elion EA, Qi M, Chen W. Signal transduction. signaling specificity in yeast. Science. 2005;307:687–8. [PubMed]

5. Goldbeter A, Koshland JD E. An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci U S A. 1981;78:6840–4. [PubMed]

6. Qiao L, Nachbar RB, Kevrekidis IG, Shvartsman SY. Bistability and oscillations in the huang-ferrell model of mapk signaling. PLoS Comput Biol. 2007;3:1819–26. [PMC free article] [PubMed]

7. Feliu E, Knusden M, Andersen L, Wiuf C. An algebraic approach to signaling cascades with n layers. Bull Math Biol. 2012;74:45–72. [PubMed]

8. Ventura AC, Sepulchre JA, Merajver SD. A hidden feedback in signaling cascades is revealed. PLoS Comput Biol. 2008;4:e1000041. [PMC free article] [PubMed]

9. Del Vecchio D, Ninfa AJ, Sontag ED. Modular cell biology: retroactivity and insulation. Mol Syst Biol. 2008;4:161. [PMC free article] [PubMed]

10. Ossareh HR, Ventura AC, Merajver SD, Del Vecchio D. Long signaling cascades tend to attenuate retroactivity. Biophys J. 2011;100:1617–26. [PubMed]

11. Andrianantoandro E, Basu S, Karig DK, Weiss R. Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2: 2006 0028. 2006. [PMC free article] [PubMed]

12. Franco E, Del Vecchio D, Murray R. Design of insulating devices for in vitro synthetic circuits. In: Proceedings of the IEEE Conference on Decision and Control, Shangai. 2009. pp. 4584–4589.

13. Anderson J, Chang Y, Papachristodoulou A. Model decomposition and reduction tools for large-scale networks in systems biology. Automatica. 2011;47:1165–1174.

14. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature. 1999;402:C47–52. [PubMed]

15. Alexander RP, Kim PM, Emonet T, Gerstein MB. Understanding modularity in molecular networks requires dynamics. Sci Signal. 2009;2:pe44. [PubMed]

16. Wynn M, Ventura A, Sepulchre JA, Garca H, Merajver S. Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity. BMC Systems Biology. 2011;5:156. [PMC free article] [PubMed]

17. Kim Y, Paroush Z, Nairz K, Hafen E, Jimenez G, et al. Substrate-dependent control of mapk phosphorylation in vivo. Mol Syst Biol. 2011;7:467. [PMC free article] [PubMed]

18. Ventura AC, Jiang P, Van Wassenhove L, Del Vecchio D, Merajver SD, et al. Signaling properties of a covalent modification cycle are altered by a downstream target. Proc Natl Acad Sci U S A. 2010;107:10032–7. [PubMed]

19. Kim Y, Coppey M, Grossman R, Ajuria L, Jimenez G, et al. Mapk substrate competition integrates patterning signals in the drosophila embryo. Curr Biol. 2010;20:446–51. [PMC free article] [PubMed]

20. Goldbeter A. A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc Natl Acad Sci U S A. 1991;88:9107–11. [PubMed]

21. Callis J, Vierstra RD. Protein degradation in signaling. Curr Opin Plant Biol. 2000;3:381–6. [PubMed]

22. Soyer OS, Kuwahara H, Csikasz-Nagy A. Regulating the total level of a signaling protein can vary its dynamics in a range from switch like ultrasensitivity to adaptive responses. FEBS J. 2009;276:3290–8. [PubMed]

23. Kumar N, Afeyan R, Kim HD, Lauffenburger DA. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of her2-overexpressing mammary epithelial cells. Mol Pharmacol. 2008;73:1668–78. [PubMed]

24. Jiang P, Ventura AC, Sontag ED, Merajver SD, Ninfa AJ, et al. Load-induced modulation of signal transduction networks. Sci Signal 4. 2011. [PubMed]

25. Zumsande M, Gross T. Bifurcations and chaos in the mapk signaling cascade. J of Theor Biol. 2010;265:481–491. [PubMed]

Articles from PLoS ONE are provided here courtesy of **Public Library of Science**

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's national science library in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |